Key result
Percutaneous ASD closure eliminates left-to-right shunt and reverses right-heart dilation in an elite athlete.
Why the study?
Echocardiography can reveal silent congenital anomalies in highly trained young athletes not detected by clinical examination or ECG.
Case Report (n=1)
Echocardiography during pre-participation screening can identify clinically silent but hemodynamically significant congenital heart anomalies like ASDs in high-level athletes, allowing for successful percutaneous intervention.
Answers are grounded in this paper and cite their sources.
Should not yet change practice for asymptomatic ASD in elite youth athletes; hypothesis-generating for right-heart remodeling benefits.
Pre-participation cardiovascular evaluation aims to detect occult cardiac conditions that may increase the risk of sudden cardiac events in young athletes. Although echocardiography is not universally recommended for systematic screening, it can reveal silent congenital anomalies, particularly in highly trained individuals. In this report, we describe a case of a 14-year-old competitive football player with no prior medical history who underwent routine pre-participation evaluation. Clinical examination and resting electrocardiogram were normal. Transthoracic echocardiography (TTE), however, revealed an ostium secundum atrial septal defect (ASD) with mildly enlarged right chambers and a Qp/Qs ratio of 1.7, in the absence of pulmonary hypertension. Transesophageal echocardiography (TEE) confirmed adequate rims for device closure. Percutaneous occlusion using an ASD device was successfully performed without complications. Follow-up at one and three months confirmed appropriate device positioning and regression of right-heart dilation. This case highlights the potential role of echocardiography in uncovering silent congenital heart disease (CHD) in young athletes. Although routine TTE screening is not recommended for the general athletic population, selected high-level athletes may benefit from imaging to detect structural anomalies not identifiable clinically. The literature supports early identification and percutaneous treatment of significant ASDs to prevent long-term right-heart remodeling and adverse outcomes.
No takes yet. Share an insight, caveat, or question.
A 2025 study conducted a case report in Atrial septal defect (n=1). Percutaneous atrial septal defect closure was evaluated on Device positioning and regression of right-heart dilation. Percutaneous closure of an asymptomatic ostium secundum atrial septal defect in a 14-year-old elite athlete successfully eliminated the left-to-right shunt and led to regression of right-heart dilation.
Synapse has enriched 10 related papers. Consider them for comparative context: